Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Identification of pathogenic TRAIL-expressing innate immune cells during HIV-1 infection in humanized mice by scRNA-Seq
Liang Cheng, Haisheng Yu, John A. Wrobel, Guangming Li, Peng Liu, Zhiyuan Hu, Xiao-Ning Xu, Lishan Su
Liang Cheng, Haisheng Yu, John A. Wrobel, Guangming Li, Peng Liu, Zhiyuan Hu, Xiao-Ning Xu, Lishan Su
View: Text | PDF
Resource and Technical Advance AIDS/HIV

Identification of pathogenic TRAIL-expressing innate immune cells during HIV-1 infection in humanized mice by scRNA-Seq

  • Text
  • PDF
Abstract

Depletion of CD4+ T cells during HIV-1 infection is mostly mediated by inflammatory cells via indirect but not clearly defined mechanisms. In this report, we used single-cell RNA-Seq (scRNA-Seq) technology to study HIV-induced transcriptomic change in innate immune cells in lymphoid organs. We performed scRNA-Seq on hCD45+hCD3–hCD19– human leukocytes isolated from spleens of humanized NOD/Rag2–/–γc–/– (NRG) mice transplanted with human CD34+ hematopoietic stem progenitor cells (NRG-hu HSC mice). We identified major populations of innate immune cells, including plasmacytoid dendritic cells (pDCs), myeloid dendritic cells (mDCs), macrophages, NK cells, and innate lymphoid cells (ILCs). HIV-1 infection significantly upregulated genes involved in type I IFN inflammatory pathways in each of the innate immune subsets. Interestingly, we found that TRAIL was upregulated in the innate immune populations, including pDCs, mDCs, macrophages, NK cells, and ILCs. We further demonstrated that blockade of the TRAIL signaling pathway in NRG-hu HSC mice prevented HIV-1–induced CD4+ T cell depletion in vivo. In summary, we characterized HIV-induced transcriptomic changes of innate immune cells in the spleen at single-cell levels, identified the TRAIL+ innate immune cells, and defined an important role of the TRAIL signaling pathway in HIV-1–induced CD4+ T cell depletion in vivo.

Authors

Liang Cheng, Haisheng Yu, John A. Wrobel, Guangming Li, Peng Liu, Zhiyuan Hu, Xiao-Ning Xu, Lishan Su

×

Figure 4

Blocking TRAIL signaling in vivo prevents HIV-1–induced CD4+ T cell depletion.

Options: View larger image (or click on image) Download as PowerPoint
Blocking TRAIL signaling in vivo prevents HIV-1–induced CD4+ T cell depl...
(A) Representative FACS plots and summarized data show expression of DR5 on CD4+ T (CD3+CD8–) cells from mock and HIV-1–infected mice 3–5 weeks after HIV-1 infection. Combined data from 2 independent experiments. Mock, n = 5; HIV-1, n = 7. Data represent mean ± SEM. *P < 0.05, by 2-tailed Student’s t test. (B–E) NRG-hu HSC mice infected with HIV-1 were treated with sDR5-Ig or control Ig twice a week (200 μg/mouse, intraperitoneal injection) from 5 to 35 days after infection. (B) Plasma HIV-1 RNA levels are shown at indicated time points after HIV-1 infection. (C and D) Numbers of CD4+ T cells (CD3+CD8–) in peripheral blood (C) and spleens (D) at termination (day 35) are summarized. (E) Representative FACS plots and summarized data showing the percentage of splenic CD4+ T cells (CD3+CD8–) expressing active caspase-3. Mock, n = 5; HIV-1+control Ig, n = 5; HIV-1+DR5-Ig, n = 5. Data represent mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, by 1-way ANOVA and Bonferroni’s post hoc test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts